Orchard Therapeutics

Bobby Gaspar, M.D., Ph.D., CEO

London, United Kingdom

(NASDAQ: ORTX)

Virtual Presentation

Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by severe diseases through the development of innovative, potentially curative gene therapies. Our ex vivo autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration.

www.orchard-tx.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions